The maturing regulatory landscape for companion diagnostics and IVD in the UK and Europe, along with new technologies like AI/ML, next-generation sequencing, and genetic-based diagnostics, has brought us to a pivotal point where personalized medicines for all patients are within reach. Join us at the 6th Annual Biomarker and Companion Diagnostics Conference, scheduled for March 13th-14th, 2025, in London, UK.
The 2025 programme will delve into the intricacies of navigating regulatory barriers with a specific focus on companion diagnostics (CdX) and the complexities of biomarkers. Come together on this dynamic platform where we foster collaboration, share knowledge, and explore cutting-edge research and applications. Esteemed keynote speakers will provide groundbreaking insights into the latest developments and future prospects of biomarker research, fostering collaboration and driving innovation in the field of companion diagnostics.
Anticipated as one of the most prominent industry-led meetings, this conference unites over 200 senior decision-makers in the biomarker and CDx fields, offering unparalleled insights. Attendees will gain practical knowledge to identify advancements in Translational Medicine and Precision Medicine development across both oncology and non-oncology indications encompassing modalities such as gene therapy and protein degradation, and novel biomarkers such as cfDNA and circulating histones, among many others.
Join us in exploring these transformative subjects and advancing the future of personalized medicine.
London, UK
